Russell Investments Group
NYMX

Russell Investments Group’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Russell Investments Group’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-21,941
Closed -$54K – 3220
2020
Q4 		$54K Sell
21,941
-47,056
-68% -$104K ﹤0.01% 2920
2020
Q3 		$169K Buy
+68,997
New +$201K ﹤0.01% 2836

Other funds holding NYMX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Russell Investments Group's NYMX Position: Q1 2021 in Review

Russell Investments Group sold out of Nymox Pharmaceutical Corp (NYMX) in Q1 2021, closing a stake of 21,941 shares — an estimated $54K sold.

Russell Investments Group first reported a position in NYMX in Q3 2020 and held it in 2 quarters. The position peaked at $169K in Q3 2020. 59 funds tracked by Wall St. Rank hold NYMX as of Q1 2021.

  • Russell Investments Group reported no remaining Nymox Pharmaceutical Corp position as of Q1 2021 after selling out during the quarter.
  • Russell Investments Group sold 21,941 Nymox Pharmaceutical Corp shares in Q1 2021, an estimated $54K.
  • Russell Investments Group first reported a position in Nymox Pharmaceutical Corp in Q3 2020 and held it in 2 quarters.
  • Russell Investments Group's Nymox Pharmaceutical Corp position peaked at $169K in Q3 2020.
  • 59 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q1 2021.

Based on Russell Investments Group's 13F filing for Q1 2021, filed 10 May 2021.